Clinical Trial Update: Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for Biostate, a pd VWF/FVIII concentrate, in patients with Von Willebrand Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Biostate (plasma-derived von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Von Willebrand Disease | Phase 2, Phase 3 | Status: COMPLETED